Registration now is open for the 2026 Midwest Radiation Oncology Symposium, to be held Aug. 21-22 at the Fred & Pamela Buffett Cancer Center, with a virtual attendance option.
As cancer care enters a new era – defined by rapid advances in biology, technology and multidisciplinary treatment approaches – clinical decision-making has become increasingly complex, requiring an integrated and patient-centered approach.
This symposium brings together key developments in tumor biology, contemporary clinical management and innovations in radiation oncology to provide a cohesive framework for learning and discussion.
Participants will explore:
- How emerging insights into treatment response and resistance are shaping care.
- How multidisciplinary strategies are evolving across challenging disease sites.
- How technologies such as adaptive radiotherapy, digital modeling and artificial intelligence are influencing workflow and personalization.
By linking science, clinical evidence and technology, this symposium aims to strengthen participants’ ability to optimize treatment selection, reduce toxicity and improve patient outcomes and quality of life.
Registration closes on Aug. 14.
For more information, including cost, continuing education accreditation and credits, or to register, visit the event website. Fellows, residents and students may attend this symposium for free.